Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents | Zendy

Christoph Kaiser | Zendy; S. Galatius | Zendy; Raban Jeger | Zendy; Nicole Gilgen | Zendy; Jan Skov Jensen | Zendy; Christoph Naber | Zendy; Hannes Alber | Zendy; Maria Wanitschek | Zendy; Franz R. Eberli | Zendy; David J. Kurz | Zendy; Giovanni Pedrazzini | Zendy; Tiziano Moccetti | Zendy; Hans Rickli | Zendy; Daniel Weilenmann | Zendy; A.G. Vuillomenet | Zendy; Martin Steiner | Zendy; Stefanie von Felten | Zendy; D. Vogt | Zendy; Kim Wadt Hansen | Zendy; Peter Rickenbacher | Zendy; David Conen | Zendy; Christian Müller | Zendy; Peter Buser | Zendy; Andreas Hoffmann | Zendy; Matthias Pfisterer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents

Author(s) -

Christoph Kaiser,

S. Galatius,

Raban Jeger,

Nicole Gilgen,

Jan Skov Jensen,

Christoph Naber,

Hannes Alber,

Maria Wanitschek,

Franz R. Eberli,

David J. Kurz,

Giovanni Pedrazzini,

Tiziano Moccetti,

Hans Rickli,

Daniel Weilenmann,

A.G. Vuillomenet,

Martin Steiner,

Stefanie von Felten,

D. Vogt,

Kim Wadt Hansen,

Peter Rickenbacher,

David Conen,

Christian Müller,

Peter Buser,

Andreas Hoffmann,

Matthias Pfisterer

Publication year - 2014

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.114.013520

Subject(s) - medicine , myocardial infarction , stent , clinical endpoint , aspirin , surgery , cardiology , randomized controlled trial

Biodegradable-polymer drug-eluting stents (BP-DES) were developed to be as effective as second-generation durable-polymer drug-eluting stents (DP-DES) and as safe >1 year as bare-metal stents (BMS). Thus, very late stent thrombosis (VLST) attributable to durable polymers should no longer appear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research